There are many companies that are expected to be in focus among investors today and one of those could well be CV Sciences Inc (OTCMKTS:CVSI) following the developments from yesterday. It is one of the leaders in the fast-growing wellness industry and yesterday the company made an announcement with regard to one of its products.
CV Sciences, Inc. Launches 30-Count of Popular +PlusCBD™ Reserve Collection Softgels
CV Sciences announced that its popular +PlusCBD Reserve Collection Softgels would be made available in a 30-count bottle. The company also announced that the product would be made available on its website from January 19, 2023. Considering the fact that the product would go on sale today, it is going to be interesting to see if it leads to any traction for the CV Sciences stock.
The product had initially been launched back in August last year as one of the latest additions to the company’s highly popular Reserve Collection. The product had been made available in 60-count bottles at that point. The product is meant for consumption in microdoses. The availability of the 30-count bottle is going to allow consumers to customize the extent of their own dosage with greater ease.
 Stock Continues To Gain Momentum){kind=link}